CC2 Lab 13
CC2 Lab 13
+Plasma → In plasma the anticoagulant that we’ll use Immunologic Assays→ hormone determination
depends on what type of hormone we are looking for → most widely used method for quantitating hormones in
• EDTA – ACTH, ADH, PTH (parathyroid which a labeled antibody would be used to determine
hormone) together with non-isotopic
• Heparin – Catecholamines, cortisol, ➢ depends on the specific type of immunologic
dopamine, FSH assay to be used
+Serum – aldosterone, androstenedione, DHEA
(dehydroepiandrosterone), estrogen, FSH, GH • RIA (radioimmunoassay) – a type of competitive
(growth hormone), HCG, progesterone protein binding technique which uses
radioactive isotopes as the label, it uses a radio
+Urine – estriol labelled hormone as the TAG hormone and an
→ In urine sample we may use different types of anti-sera which prepared against the specific
preservatives with varying volumes hormone which would act as a binding site
o CPB technique that utilizes radio-
• Boric Acid (1g/dL) – estriol and estrogen → labeled hormones as the tagged
used to preserves urine samples up to 7 hormone and anti-sera prepared
days against the specific hormone as a
• 10 mL of 6N HCl (hydrochloric acid) – 3-4 L binding site
container → for preserving urine samples for
catecholamines, VMA (vanillylmandelic acid), • IRMA (immunoradiometric assay) – which
5-HIAA uses Radiolabeled substance that is attached
• HCl (hydrochloric acid) → maintains pH of to the antibody instead of the hormone.
<3.0 → chemical testing (preferred o the means of detection is based on Ag-
preservative for chemical testing) Ab reaction. (Antigen-antibody reaction)
TRIIODOTHYRONINE MEASUREMENT
• Detection of autoantibody against the TSH
• Total triiodothyronine could also be measured. It receptor or the anti-TSH receptor
also known as the total T3 or the TT3 → Used for diagnosis of Grave’s disease
• This measures the level of total T3 in the blood
• Used for evaluating as well as management of • Autoantibodies will be detected based on
thyroid dysfunction, including hyperthyroidism the interference with the binding of the TSH-
• This one is typically measured together with the to-TSH receptor
free T3 and T4 as well as TSH and T3 uptake • detects autoantibodies that interfere with the
binding of TSH-to-TSH receptor
• Related tests: FT4, T3 uptake, ft3 and TSH • serum + TSH receptor + I125 labelled TSH
evaluation tracer
• Adults: 60-181 ng/dL (0.92-2.78 nmol/L)
→ The serum sample would be mixed with the reagent
• Pregnancy (last 5 mos): 116-247 ng/dL
containing the TSH receptor and an iodine labelled TSH
(1.79-3.8 nmol/L)
tracer
SERUM TOTAL T4 using COMPETITIVE
• MEASURED: amount of free tracer
IMMUNOASSAY
o expected is lower than 9 U/L tracer
• measures the total amount of to be considered normal
thyroxine/T4 → when we say total this means
THYROTROPIN RELEASING HORMONE (TRH)
both free and CHON bound (protein bound)
STIMULATION TEST
thyroxine present in blood
→ one of a many specific tests for determination of
→ compound which is being used for competitive thyroid disorder
immunoassay would be dependent on what it would
compete with • There would be an injection of TRH and
measurement of the output of TSH as a
• uses barbital buffers (vs TBPA) and 8-
reaction from the reaction made by the
anilino-1- naphthalene-sulfonic acid (vs TBG
injection of the TRH
or thyroxine binding globulin)
• specifically used in the diagnosis of combined
→ Barbital buffers would be used if the competitive pituitary thyroid disorders
immunoassay would be involving the used of TBPA • differentiates 2° secondary hypothyroidism to
(thyroxine binding prealbumin) while 8- anilino-1 3° tertiary hypothyroidism
napthalene-sulfonic acid would be used if the competitive TEST FOR THYROID FUNCTION
immunoassay would be involving TBG (thyroxine binding
globulin) TRH Stimulation Test
o Adults: 4.5-10.9 µg/dL (58-140 • The most specific and sensitive test for
nmol/L) the measurement / determination of the
relationship between TRH and TSH
• Measures relationship between TRH and
TSH
• Helpful in the detection of thyroid
hormone resistance syndromes.
• Dose needed: 500 ug or microgram of TRH
by administered by IV
4|CC2 LAB 13
Expected result: BMR: (basal metabolic rate) of the body
reference range:
• Decrease= t3, t4, ft4, rt3, tg • Insulin Tolerance Test – gold standard for
• normal= may also be normal tg and tbg and testing the growth hormone deficiency
• increase- tsh • Arginine Stimulation Test - 2nd
Confirmatory Test
Nonthyroidal illness:
→ These two tests involve measurement or monitoring
• Decrease- t3, t4, growth hormone during nighttime or a 24 hour period
• Variation- TSH, ft4
• Increase- rt3 • Procedure: 24-hour or nighttime monitoring
of GH
• Normal- tg, tbg or normal t4, rt3
Interpretation:
Thyroid hormone resistance: all are expected to
increase except for tbg and tsh may be normal or • Confirmation of growth hormone
increase deficiency if → Failure of GH to rise above
Neonatal hypothyroidism: o > not beyond 5ng/mL (adults)
o > fails to increase by 10 mg/mL
• Decreased- t3, t4, ft4, rt3, tg may be (child) in all the tests is confirmed
decreased or normal GH deficiency
• Normal- tbg
7|CC2 LAB 13
Test for Acromegaly • Mab 1-hGH-Mab-HRP
• absorbance is measured after colorimetric
→ Acromegaly- is defined as a hormonal disorder which
reaction
could develop whenever the pituitary gland produces too
• Growth hormone concentration would vary
much growth hormone during adulthood depending on what time of the day the
Screening Test: Somatomedin C or insulin like immunoassay is being done because growth
growth factor 1 hormone is released at certain time of the
day
• IGF-1 is produced in the liver o Day: <0.2-10 uIU/mL
• Increased in patients with Acromegaly o Night: 30 uIU/mL
• Low in growth hormone deficiency (GHD)
Prolactin Immunoassay
Confirmatory Test: Glucose Suppression Test –
OGTT → which would be done just like the oral glucose → Principle: homologous competitive binding
tolerance test immunoassay/ sandwich technique
• Blood would collect every after 30 mins for 2 Sandwich technique → since it uses two or more
hours: fasting sample is required antibodies directed at different parts of the (PRL)
• This test method is considered to be the prolactin molecule
BEST METHOD in confirming acromegaly
• Affected by → hook effect- happens when
diagnosis and in people who does not have
there is an excess antigen during testing,
acromegaly it is expected that the glucose
dilution could be done to counteract this
strength drink should typically cause growth
phenomenon
hormone level to fall and vice versa to
o Adult male: 3-14.7 ng/mL or ug/L
patients who those has acromegaly
o Adult female: 3.8-23 ng/mL or ug/L
OTHER TEST FOR DETERMINING GROWTH o Pregnancy, 3rd tri: 95-473 ng/mL
HORMONE
Phase of Cycle
→ The absorbance reading would be DIRECTLY • high estradiol (D3): poor ovarian reserve
PROPORTIONAL to LH concentration • estradiol rises as follicle matures; useful for
measuring follicular activity
→ more luteinizing hormone found = higher absorbance • mature follicles to release about > 200-300
reading pg/ml of estradiol
- Mab1-LH-Mab2HRP • more than P >15 ng/ml about 7 days after
o measured using chromogenic ovulation: corpus luteum is functioning
reaction normally → EXPECTED ACTIVITY / RELEASE
10 | C C 2 L A B 1 3
• low Day 21 Progesterone level → suggests o 270-280 mOsm/kg: <1.5 pg/mL
the cycles was anovulatory (no egg was (<1.4 pmol/L)
produced) o 280-285 mOsm/kg: <2.5 pg/mL
(<2.3 pmol/L)
Serum FSH Measurement (IRMA) o 285-290 mOsm/kg: 1-5 pg/mL (0.9-
4.6 pmol/L)
• uses immune radiometric assay
o 290-295 mOsm/kg: 2-7 pg/mL (1.9-
• sandwich method also using monoclonal
6.5 pmol/L)
antibody another monoclonal body and another
o 295-300 mOsm/kg: 4-12 pg/mL (3.7-
monoclonal body which would be labeled by
11.1 pmol/L)
radio metric iodine
• used to assess and manage disorders of the
endocrine gland involving suspected infertility
this is related to the previous tests discussed for
fertility testing (luteinizing hormone, prolactin,
estradiol, testosterone,
• Female, menstruating:
o Follicular phase: 1.4-9.9 mIU/mL
(1.4-9.9 IU/L)
o Ovulatory phase: 0.2-17.2 mIU/mL
(0.2-17.2 IU/L)
o Luteal phase: 1.1-9.2 mIU/mL (1.1-
9.2 IU/L)
• Postmenopausal: 19.3-100.6 IU/L
• Male: 1-15.4 mIU/mL (1-15.4 IU/L)
ADH Measurement